908 Devices Inc.
$12.85-$0.02 (-0.16%)
908 Devices Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.75% below the high.
NASDAQ · VMD · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Viemed Healthcare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 21.09% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Viemed Healthcare, Inc.’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of $0.12. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Viemed Healthcare, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:24 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 7, 2025 | $0.060.0% vs estimate | $59.13M-2.43% vs estimate |
|---|
| Q4 2024 | Mar 10, 2025 | $0.10-9.09% vs estimate | $60.70M+2.18% vs estimate |
|---|
| Q3 2024 | Nov 6, 2024 | $0.10+25.0% vs estimate | $58.00M-2.35% vs estimate |
|---|
THE ANALYST VIEW
2 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 1 contributors · Median target $14.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$12.85-$0.02 (-0.16%)
908 Devices Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.75% below the high.
$9.57+$0.33 (+3.57%)
Sight Sciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.47% below the high.
$9.75+$0.41 (+4.39%)
Senseonics Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.36% below the high.
$27.68+$0.40 (+1.47%)
Electromed, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.6% below the high.
$7.26+$0.01 (+0.14%)
Inogen, Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.09% below the high.
$3.15+$0.03 (+0.8%)
Quanterix Corporation’s quoted price sits in the lower half of its reported 52-week range, 64.14% below the high.
$4.19-$0.15 (-3.46%)
Outset Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.71% below the high.
$5.27$0.00 (0.0%)
SANUWAVE Health Inc.’s quoted price sits in the lower half of its reported 52-week range, 85.44% below the high.